Correlation Between Cadrenal Therapeutics, and Senti Biosciences
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Senti Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Senti Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Senti Biosciences, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Senti Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Senti Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Senti Biosciences.
Diversification Opportunities for Cadrenal Therapeutics, and Senti Biosciences
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cadrenal and Senti is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Senti Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senti Biosciences and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Senti Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senti Biosciences has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Senti Biosciences go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and Senti Biosciences
Given the investment horizon of 90 days Cadrenal Therapeutics, is expected to generate 3.2 times less return on investment than Senti Biosciences. But when comparing it to its historical volatility, Cadrenal Therapeutics, Common is 2.69 times less risky than Senti Biosciences. It trades about 0.02 of its potential returns per unit of risk. Senti Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,673 in Senti Biosciences on November 2, 2024 and sell it today you would lose (1,231) from holding Senti Biosciences or give up 73.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. Senti Biosciences
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| Senti Biosciences |
Cadrenal Therapeutics, and Senti Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and Senti Biosciences
The main advantage of trading using opposite Cadrenal Therapeutics, and Senti Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Senti Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will offset losses from the drop in Senti Biosciences' long position.The idea behind Cadrenal Therapeutics, Common and Senti Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |